Novartis Venture Fund
Ken Davidson is an accomplished marketing professional with extensive experience in the pharmaceutical industry. Currently serving as Executive Director and Senior Marketing Strategist at Novartis since January 2018, Ken has held various leadership roles, including overseeing marketing strategies for Leqvio and leading HCP marketing efforts in neuroscience for drugs such as Mayzent and Gilenya. Prior to Novartis, Ken was Global Manager for Product Marketing at Celgene, focusing on Otezla in Inflammation and Immunology. Ken's earlier tenure at AstraZeneca involved multiple marketing and sales positions across diabetes and cardiovascular products. Ken began the career in account management at Coca-Cola Enterprises. Educational qualifications include an Advanced Marketing Capabilities Program from The Wharton School, an M.B.A. in Marketing and Finance from Seton Hall University, and a Bachelor of Arts from Eckerd College.
This person is not in any teams
This person is not in any offices
Novartis Venture Fund
3 followers
Novartis Venture Fund's primary focus is on the development of novel therapeutics and platforms. In their investments, they look for unmet need and clinical impact, novel proprietary science, and understanding of the mechanism, management, and board experience and capital efficiency in the program.